BETRF
Price
$0.06
Change
-$0.00 (-0.00%)
Updated
Jun 26 closing price
Capitalization
11.14M
BIXT
Price
$0.11
Change
-$0.00 (-0.00%)
Updated
Jun 27 closing price
Capitalization
9.39M
Interact to see
Advertisement

BETRF vs BIXT

Header iconBETRF vs BIXT Comparison
Open Charts BETRF vs BIXTBanner chart's image
BETTERLIFE PHARMA
Price$0.06
Change-$0.00 (-0.00%)
Volume$1K
Capitalization11.14M
Bioxytran
Price$0.11
Change-$0.00 (-0.00%)
Volume$38.01K
Capitalization9.39M
BETRF vs BIXT Comparison Chart in %
Loading...
BETRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BIXT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BETRF vs. BIXT commentary
Jul 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BETRF is a Hold and BIXT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 01, 2025
Stock price -- (BETRF: $0.06 vs. BIXT: $0.11)
Brand notoriety: BETRF and BIXT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BETRF: 3% vs. BIXT: 25%
Market capitalization -- BETRF: $11.14M vs. BIXT: $9.39M
BETRF [@Biotechnology] is valued at $11.14M. BIXT’s [@Biotechnology] market capitalization is $9.39M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BETRF’s FA Score shows that 0 FA rating(s) are green whileBIXT’s FA Score has 0 green FA rating(s).

  • BETRF’s FA Score: 0 green, 5 red.
  • BIXT’s FA Score: 0 green, 5 red.
According to our system of comparison, BETRF is a better buy in the long-term than BIXT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BETRF’s TA Score shows that 2 TA indicator(s) are bullish while BIXT’s TA Score has 1 bullish TA indicator(s).

  • BETRF’s TA Score: 2 bullish, 5 bearish.
  • BIXT’s TA Score: 1 bullish, 6 bearish.
According to our system of comparison, BETRF is a better buy in the short-term than BIXT.

Price Growth

BETRF (@Biotechnology) experienced а -18.52% price change this week, while BIXT (@Biotechnology) price change was -3.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.69%. For the same industry, the average monthly price growth was +32.93%, and the average quarterly price growth was +6.81%.

Industries' Descriptions

@Biotechnology (+3.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BETRF($11.1M) has a higher market cap than BIXT($9.39M). BIXT YTD gains are higher at: 17.375 vs. BETRF (-15.724). BIXT has higher annual earnings (EBITDA): -2.38M vs. BETRF (-3.14M). BETRF has more cash in the bank: 18.7K vs. BIXT (4.35K). BETRF (1.24M) and BIXT (1.26M) have identical debt. BETRF (0) and BIXT (0) have equivalent revenues.
BETRFBIXTBETRF / BIXT
Capitalization11.1M9.39M118%
EBITDA-3.14M-2.38M132%
Gain YTD-15.72417.375-90%
P/E RatioN/AN/A-
Revenue00-
Total Cash18.7K4.35K430%
Total Debt1.24M1.26M98%
FUNDAMENTALS RATINGS
BETRF vs BIXT: Fundamental Ratings
BETRF
BIXT
OUTLOOK RATING
1..100
5059
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
85
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
6565
P/E GROWTH RATING
1..100
44100
SEASONALITY SCORE
1..100
95n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BIXT's Valuation (85) in the null industry is in the same range as BETRF (100). This means that BIXT’s stock grew similarly to BETRF’s over the last 12 months.

BIXT's Profit vs Risk Rating (100) in the null industry is in the same range as BETRF (100). This means that BIXT’s stock grew similarly to BETRF’s over the last 12 months.

BIXT's SMR Rating (100) in the null industry is in the same range as BETRF (100). This means that BIXT’s stock grew similarly to BETRF’s over the last 12 months.

BIXT's Price Growth Rating (65) in the null industry is in the same range as BETRF (65). This means that BIXT’s stock grew similarly to BETRF’s over the last 12 months.

BETRF's P/E Growth Rating (44) in the null industry is somewhat better than the same rating for BIXT (100). This means that BETRF’s stock grew somewhat faster than BIXT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BETRFBIXT
RSI
ODDS (%)
N/A
Bullish Trend 4 days ago
72%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
78%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
83%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
Bearish Trend 4 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
84%
N/A
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
BETRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BIXT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HUFAF12.20N/A
N/A
Hufvudstaden AB
OROVY84.71N/A
N/A
Orient Overseas International Ltd.
SEIGF15.96N/A
N/A
Semperit Ag Holding
FRFFF18.29N/A
N/A
Fairfax Financial Holdings Ltd.
ROOOF0.25-0.01
-4.87%
NORTHSTAR CLEAN TECHNOLOGIES INC.

BETRF and

Correlation & Price change

A.I.dvisor tells us that BETRF and AVCTF have been poorly correlated (+14% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BETRF and AVCTF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BETRF
1D Price
Change %
BETRF100%
N/A
AVCTF - BETRF
14%
Poorly correlated
N/A
BPMUF - BETRF
6%
Poorly correlated
N/A
BIXT - BETRF
3%
Poorly correlated
-5.70%
AURX - BETRF
-0%
Poorly correlated
N/A
AMGXF - BETRF
-2%
Poorly correlated
N/A
More

BIXT and

Correlation & Price change

A.I.dvisor tells us that BIXT and CING have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BIXT and CING's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIXT
1D Price
Change %
BIXT100%
-5.70%
CING - BIXT
26%
Poorly correlated
-1.22%
CYTK - BIXT
22%
Poorly correlated
-2.21%
APLM - BIXT
21%
Poorly correlated
+1.51%
ANEB - BIXT
20%
Poorly correlated
+2.11%
TTNP - BIXT
20%
Poorly correlated
-1.79%
More